The Medicaid and CHIP Payment and Access Commission approved recommendations it will issue to Congress in its June report on oversight and increased transparency of artificial intelligence usage for prior authorization. The commission recommended that the Centers for Medicare & Medicaid Services clarify federal requirements that, for determinations of medical necessity, all adverse determinations, such as denials or reductions in requested services, must be reviewed and authorized by an individual with appropriate expertise and may not be made by automation tools alone. It also recommended CMS amend fee-for-service regulations to establish similar requirements and issue guidance on oversight of managed care use of automation, and that states require Medicaid health plans to disclose their use of automation, including testing, evaluation and oversight. 

Headline
Hospital and health system leaders gathered June 17 and 18 in Washington, D.C., for U.S. News & World Report’s Healthcare of Tomorrow Conference, focusing…
Headline
The AHA drafted and filed an amicus brief June 17 in the 5th U.S. Circuit Court of Appeals in a case regarding Medicaid financing and provider taxes filed by…
Headline
The AHA provided comments June 15 to the Centers for Medicare & Medicaid Services on its proposed rule establishing electronic standards for drug prior…
Headline
The Medicaid and CHIP Payment and Access Commission June 15 released its June 2026 report to Congress. Among the topics discussed, chapter two focuses on…
Headline
The AHA provided a statement to the House Energy and Commerce Subcommittee on Health today for a hearing titled “Lowering Health Care Costs for All Americans:…
Headline
The White House issued an executive order June 2 on cybersecurity efforts regarding artificial intelligence. The order instructs federal…